Key result
Cardiogenic shock in ACS is linked to significantly elevated IL-8, IL-18, and IL-1β.
Why the study?
The clinical, hemodynamic, metabolic, and inflammatory profiles of ACS patients with and without cardiogenic shock and associated biomarkers of disease severity were not well characterized.
Observational (n=76)
Acute coronary syndrome complicated by cardiogenic shock is characterized not only by hemodynamic failure but also by a distinct inflammatory cytokine profile, highlighting a potential role for inflammation in disease severity.
May inform shock risk stratification in ACS; leaves open whether cytokine modulation improves outcomes.
OBJECTIVE: To compare the clinical, hemodynamic, metabolic and inflammatory profiles of patients with acute coronary syndrome (ACS) with and without cardiogenic shock (CS) and to identify biomarkers associated with disease severity. METHODS: In this observational study, 76 patients with ACS (38 with CS and 38 without CS) were enrolled. Clinical characteristics, laboratory parameters, cardiac biomarkers, lipid profile and 13 circulating cytokines were assessed. Continuous variables were compared using Welch's t-test or the Mann-Whitney U test and categorical variables using the chi-square or Fisher's exact test. Exploratory multivariable analyses adjusted for age, sex and STEMI status were performed for selected cytokines. RESULTS: Compared with patients without CS, those with CS had significantly lower blood pressure, higher shock index, reduced ejection fraction and higher CK-MB, troponin I, BNP, D-dimer, CRP, LDH, urea and liver enzyme levels. IL-8, IL-1β, IL-18, TNF-α and GM-CSF were significantly elevated in unadjusted analyses. After adjustment for age, sex and STEMI status, IL-8, IL-18 and IL-1β remained significantly associated with CS. Mortality was numerically higher in the CS group. CONCLUSION: ACS complicated by CS was associated with profound hemodynamic impairment, greater myocardial injury and an enhanced inflammatory response. These exploratory findings warrant confirmation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Mittal et al. (2026) conducted an observational in Acute coronary syndrome with and without cardiogenic shock (n=76). Cardiogenic shock vs. No cardiogenic shock was evaluated on Clinical, hemodynamic, metabolic, and inflammatory profiles (including 13 circulating cytokines). Among 76 patients with acute coronary syndrome, cardiogenic shock (n=38) was significantly associated with elevated IL-8, IL-18, and IL-1β compared to those without shock (n=38).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: